Financhill
Back

Larimar Therapeutics Quote, Financials, Valuation and Earnings

Larimar Therapeutics Price Quote

$6.85
+0.04 (+0.59%)
(Updated: September 18, 2024 at 6:55 PM ET)

Larimar Therapeutics Key Stats

Sell
38
Larimar Therapeutics (LRMR) is a Sell

Day range:
$6.36 - $6.93
52-week range:
$2.18 - $13.68
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
2.06%

Volume:
523K
Avg. volume:
405.7K
1-year change:
60.61%
Market cap:
$434.5M
Revenue:
$0
EPS:
$-1.11

How Much Does Larimar Therapeutics Make?

Data Unavailable

Is Larimar Therapeutics Growing As A Company?

Data Unavailable

Larimar Therapeutics Stock Price Performance

What Is Larimar Therapeutics 52-Week High & Low?

Larimar Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Larimar Therapeutics?

Is Larimar Therapeutics Cash Flow Positive?

  • What Is LRMR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$42.9M
  • What Is Larimar Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $161.8M
  • What Is Larimar Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$180.9M

Larimar Therapeutics Return On Invested Capital

Data Unavailable

Larimar Therapeutics Earnings Date & Stock Price

Larimar Therapeutics Competitors

Larimar Therapeutics Dividend Yield

Larimar Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -7.79%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 20.52
Upside from Last Price: 201.25%

Major Shareholders

  • How many LRMR shares are owned by institutional investors?
    104.1M LRMR shares are owned by institutional investors
  • How many LRMR shares are owned by insiders?
    1.1M LRMR shares are owned by insiders